These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7441709

  • 1. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ, Minh MG, Mignon-Conte MA, Hass S, Lambert PH, Conte JJ.
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B, Car BD, Gunn H, Roman D, Hiestand P, Mihatsch MJ.
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 4. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [Abstract] [Full Text] [Related]

  • 5. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE.
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [Abstract] [Full Text] [Related]

  • 6. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
    Zykova SN, Seredkina N, Benjaminsen J, Rekvig OP.
    Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
    [Abstract] [Full Text] [Related]

  • 7. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 8. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
    Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW.
    Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
    [Abstract] [Full Text] [Related]

  • 9. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
    Borel Y, Lewis RM, André-Schwartz J, Stollar BD, Diener E.
    J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453
    [Abstract] [Full Text] [Related]

  • 10. Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice.
    Yoshida H, Kohno A, Ohta K, Hirose S, Maruyama N, Shirai T.
    J Immunol; 1981 Aug; 127(2):433-7. PubMed ID: 6972963
    [No Abstract] [Full Text] [Related]

  • 11. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
    Dong L, Ito S, Ishii KJ, Klinman DM.
    Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA.
    Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
    [Abstract] [Full Text] [Related]

  • 13. Sequential study of C 1 q-binding substances and of anti-DNA antibodies in (NZB X NZW)F1 mice: evidence for an acute phase of the lupus disease in 2-month-old mice.
    Fournié GJ, Gayral-Ta Minh M, Haas S, Pourrat JP, Conte JJ.
    Eur J Immunol; 1979 Aug; 9(8):652-4. PubMed ID: 499331
    [Abstract] [Full Text] [Related]

  • 14. Genetic studies on the skin lupus band test in New Zealand mice.
    Furukawa F, Maruyama N, Yoshida H, Hamashima Y, Hirose S, Shirai T.
    Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
    [Abstract] [Full Text] [Related]

  • 15. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA.
    Steinberg BJ, Smathers PA, Frederiksen K, Steinberg AD.
    J Clin Invest; 1982 Sep; 70(3):587-97. PubMed ID: 6980900
    [Abstract] [Full Text] [Related]

  • 16. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 17. The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice.
    Hurd ER, Ziff M.
    Clin Exp Immunol; 1977 Jul; 29(1):132-9. PubMed ID: 302170
    [Abstract] [Full Text] [Related]

  • 18. Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice.
    Gilkeson GS, Conover J, Halpern M, Pisetsky DS, Feagin A, Klinman DM.
    J Immunol; 1998 Oct 15; 161(8):3890-5. PubMed ID: 9780154
    [Abstract] [Full Text] [Related]

  • 19. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
    Xie C, Zhou XJ, Liu X, Mohan C.
    Arthritis Rheum; 2003 Apr 15; 48(4):1080-92. PubMed ID: 12687552
    [Abstract] [Full Text] [Related]

  • 20. Dietary restrictions early and late: effects on the nephropathy of the NZB X NZW mouse.
    Friend PS, Fernandes G, Good RA, Michael AF, Yunis EJ.
    Lab Invest; 1978 Jun 15; 38(6):629-32. PubMed ID: 96299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.